Discontinuation report BRAVELLE
| Report ID | 90130 |
| Drug Identification Number | 02268140 |
| Brand name | BRAVELLE |
| Common or Proper name | UROFOLLITROPIN FOR INJECTION, PURIFIED |
| Company Name | FERRING INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | |
| Strength(s) | |
| Dosage form(s) | |
| Route of administration | |
| Packaging size | 75 IU |
| ATC code | |
| ATC description | |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2019-07-18 |
| Remaining supply date | 2019-07-18 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | BRAVELLE is discontinued. Alternate products are available by Ferring such as REKOVELLE (follitropin delta for injection, 33.3 mcg/mL rFSH). Please contact your healthcare professional. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
| Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2019-07-29 | French | Compare |
| v3 | 2019-07-29 | English | Compare |
| v2 | 2019-07-29 | English | Compare |
| v1 | 2019-07-29 | English | Compare |
Showing 1 to 4 of 4